Objective-To investigate the fetal angiotensin II type 1 receptor genotype in preeclampsia. Design-Case-control study. Population-Forty-one maternal-fetal pairs from pre-eclamptic pregnancies and 80 maternal-fetal pairs from normotensive pregnancies. Methods-Maternal and fetal DNA was genotyped at three diallelic polymorphisms, at nucleotides 573, 1062, and 1166, in the coding exon of the angiotensin II type 1 receptor gene, and at a dinucleotide repeat polymorphism in its 3' flanking region. Results-Allele and genotype frequencies at the four polymorphic regions investigated did not differ between pre-eclamptic and normotensive groups, in either fetal or maternal samples. Mothers heterozygous for the dinucleotide repeat allele designated A4 transmitted this allele to the fetus in 15 of 18 informative preeclamptic pregnancies and in eight of 26 normotensive pregnancies. This was greater than the expected probability in pre-eclamptic pregnancies (p=0.04) and less than expected in normotensive pregnancies (p<0.005). The 573T variant, which is in partial linkage disequilibrium with the A4 allele, showed a similar distortion of maternal-fetal transmission. Although pre-eclampsia presents clinically in the second half of pregnancy, impaired trophoblastic invasion of the myometrial segment of maternal spiral arteries during early pregnancy is a characteristic feature.4 The resulting altered placental haemodynamics and placental ischaemia may be factors in the aetiology of pre-eclampsia.5 The placenta is unusual among vascular beds in having no autonomic nerve supply; vascular resistance on the fetal side of the circulation is determined by humoral factors, including angiotensin II (AII), the vasoactive peptide formed by sequential cleavage of angiotensinogen by renin and angiotensin converting enzyme. Angiotensin II receptors with the pharmacological characteristics of type 1 (AT1) receptors have been found in resistance vessels in term placentae6 and are presumably encoded by the fetal gene. They are present at decreased density in term placentae from pre-eclamptic pregnancies and from pregnancies complicated by intrauterine growth retardation.7 One possible explanation is that hypo-oxygenation stimulates the fetal renin-angiotensin system8 and the resulting rise in fetal plasma angiotensin II concentrations downregulates the placental AT1 receptors.
It is widely recognised that pre-eclampsia, the severe proteinuric form of pregnancy induced hypertension, has an inherited component.' The model of inheritance has not been defined; in particular, the contribution of the fetal genotype is unclear. Epidemiological studies are consistent with dominant maternal inheritance with partial penetrance2 and fetal factors may influence penetrance. Indeed, some epidemiological evidence supports a model of gene sharing between mother and fetus in the aetiology of pre-eclampsia. 3 Although pre-eclampsia presents clinically in the second half of pregnancy, impaired trophoblastic invasion of the myometrial segment of maternal spiral arteries during early pregnancy is a characteristic feature. 4 The resulting altered placental haemodynamics and placental ischaemia may be factors in the aetiology of pre-eclampsia. 5 The placenta is unusual among vascular beds in having no autonomic nerve supply; vascular resistance on the fetal side of the circulation is determined by humoral factors, including angiotensin II (AII), the vasoactive peptide formed by sequential cleavage of angiotensinogen by renin and angiotensin converting enzyme. Angiotensin II receptors with the pharmacological characteristics of type 1 (AT1) receptors have been found in resistance vessels in term placentae6 and are presumably encoded by the fetal gene. They are present at decreased density in term placentae from pre-eclamptic pregnancies and from pregnancies complicated by intrauterine growth retardation.7 One possible explanation is that hypo-oxygenation stimulates the fetal renin-angiotensin system8 and the resulting rise in fetal plasma angiotensin II concentrations downregulates the placental AT1 receptors.
Angiotensin II stimulates placental prostacyclin secretion.9 The receptor subtype responsible has yet to be identified in the placenta. However, at least a proportion of the stimulatory effect of angiotensin II on prostaglandin synthesis in porcine vascular smooth muscle was mediated via AT, receptors.'0 Impaired secretion of vasodilatory eicosanoids antedates the onset of clinical hypertension in pre-eclampsia" and contributes to the increased maternal pressor responsiveness to infused angiotensin II in this condition.'2 It is possible that placental AT, receptor expression influences both placental haemodynamics and maternal systemic haemodynamics through its effects on placental prostaglandin secretion.
In an earlier study comparing women with pre-eclampsia with normotensive pregnant women, we found no significant difference between the two groups of women in the frequency of three diallelic polymorphisms in the coding exon of the AT, receptor gene, at nucleotides 573, 1062 and 1 166, or in the allele distribution of a dinucleotide repeat polymorphism in its 3' flanking region. '3 In this preliminary study, fetal genotyping from these 20 ,ul of mineral oil, loaded onto a thermal cycler, and denatured at 96°C for five minutes, followed by 35 cycles of 94°C for 30 seconds, 60°C for one minute, and 72°C for one minute, 10 mmol/l Tris HC1 (pH 9.0), 0.1% Triton X-100, 1.5 mmol/l MgCl2, and 1U Taq polymerase. Samples were denatured at 96°C for five minutes, followed by 35 cycles of 30 seconds at 94°C, one minute at 50°C, and one minute at 72°C, with a final 10 minute extension stage at 72°C. DNA free controls were run with each batch to detect DNA contamination of reagent solutions. PCR products were heat denatured at 96°C in 95% formamide, and resolved by electrophoresis on 6% polyacrylamide/7 mol/l urea denaturing gels run at 45 W for two hours. The gels were dried and autoradiographed. The alleles were numbered as in the original description of this polymorphism, whereby the most common allele is designated A4.'5 A sample from a single subject of genotype A4/A7 was included on every gel to ensure consistency of allele assignment. If the mother passes on the Aj allele, with probability 0.5, the probability that the pregnancy is informative (that is, the fetus has a paternal allele other than Ai) is 1-Pi for all j. Thus the probability that an Ai/Aj heterozygote passes on Aj and is informative is 0.5(1-Pi)=b.
The total probability that a maternal-fetal pair is informative is thus a+b and the probability of a mother who is heterozygous for Ai transmitting Ai, conditional on the pregnancy being informative, is al(a+b). The observed number of alleles transmitted was compared with the expected transmission, based on the estimated conditional probability, using a binomial exact test.
Results
There were no significant differences between normotensive and pre-eclamptic groups in the allele or allele from mother to fetus exceeded the expected probability (p=0.04, binomial exact test), while in the normotensive group, the A4 allele was transmitted from mother to fetus less frequently than expected (p<0.005).
Of the diallelic polymorphisms, only that at nucleotide 573 provided a sufficient number of heterozygous pregnancies for meaningful statistical analysis of allele transmission (21 pre-eclamptic, 40 normotensive). The probability of a heterozygous mother transmitting the variant 573T allele conditional on the pregnancy being informative was 0.454. The 573T allele was transmitted from mother to fetus in nine of 13 informative pre-eclamptic pregnancies, marginally more frequently than expected (p=0.07), and in five of 23 informative normotensive pregnancies, significantly less frequently than expected (p=0.02). These observations complement those relating to transmission of the dinucleotide repeat alleles, as the A4 allele and the 573T allele are in partial positive linkage disequilibrium.13
Discussion
This study provides preliminary evidence that in pre-eclampsia there is distortion of transmission from mother to fetus of an AT, receptor allele. The dinucleotide repeat allele designated A4 is transmitted in excess in preeclamptic pregnancies. A similar trend was observed in the smaller number of pregnancies informative for transmission of the 573T variant. As a corollary of this observation, these alleles are transmitted less frequently than expected in normotensive pregnancies. Dinucleotide repeats are widely distributed in the genome, and may be involved in crossover of genetic material during meiosis.'6 There is no evidence that variation in the number of repeats has functional effects, and their main value to molecular geneticists is as highly polymorphic allelic markers. The C to T mutation at nucleotide 573 similarly has no known functional effects; although it lies within the coding region of the gene, it does not alter the encoded amino acid residue. 14 Both the A4 allele and the 573T allele may therefore be acting as markers for a linked mutation at a functional site. In our earlier study of the maternal AT, receptor genotypes in this group of subjects, normotensive pregnant women possessing either one or two copies of the 573T variant had lower levels of AT, surface receptors, measured as platelet AII binding, than women homozygous for the 573C allele. '3 (n= 18) . It is worth noting that the significance values are highly sensitive to the calculated probability of allele transmission conditional on the pregnancy being informative, which is in turn dependent on estimated allele frequencies. As the value of the conditional probability of allele transmission tends towards the unconditional probability of 0.5, the observed deficit ofA4 allele transmission in normotensive pregnancies becomes less statistically significant, while the excessive allele transmission in the pre-eclamptic group becomes more significant.
In conclusion, we present preliminary evidence that in a subgroup ofpregnancies there is distortion of transmission of an AT, receptor allele variant, which appears to be associated with pre-eclampsia. These observations require independent confirmation. Increased maternal-fetal transmission of an AT, receptor allele in pre-eclampsia is consistent with a purely fetal genetic contribution; alternatively, susceptibility to pre-eclampsia may require both mother and fetus to express the same ATI receptor allele. Possible explanatory mechanisms are suggested by the observation that this variant is associated with relatively low receptor expression on the platelets of normotensive pregnant women. If the levels of receptor expression in the trophoblast and placenta are similarly genetically determined, possession of this allele by the fetus may result in relative refractoriness to the effects of angiotensin II, affecting placentation, placental prostacyclin secretion, and placental haemodynamics. 
